Yayınlanmış 1 Ocak 2011
| Sürüm v1
Dergi makalesi
Açık
New fluorine-containing hydrazones active against MDR-tuberculosis
Oluşturanlar
- 1. Charles Univ Prague, Fac Pharm, Dept Inorgan & Organ Chem, Hradec Kralove 50005, Czech Republic
- 2. Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia
- 3. Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Peptide Chem, H-1117 Budapest, Hungary
- 4. Ctr Hyg Labs, Inst Publ Hlth, Ostrava 70200, Czech Republic
Açıklama
Several new fluorine-containing hydrazones were synthesized and screened for their in vitro anti-mycobacterial activity. Nine of these derivatives have shown a remarkable activity against MDR-TB strain with MIC 0.5 mu g/mL and high value of selectivity index (SI). Compound 3h with the highest SI (1268.58) was used for stability evaluation with putative metabolites (ciprofloxacin and formylciprofloxacin) detection. Compound 3h was stable at pH 7.4 of aqueous buffer and rat plasma, in acidic buffers (at pH 3 and 5) slow decomposition was observed. Interestingly, no formylciprofloxacin was detected in the solution, and only slightly increased concentration of ciprofloxacin was observed instead. Trifluoromethyl hydrazones 3f and 3g exhibited the best activity also against two strains of Mycobacterium kansasii (MIC 1-4 mu mol/L). All evaluated compounds were found to be non-cytotoxic. (C) 2011 Elsevier Masson SAS. All rights reserved.
Dosyalar
bib-e6b845d0-611e-40b6-9c6f-ddf0ae4cc7a5.txt
Dosyalar
(242 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:ae833454804bcfd6131b29c9be0a4997
|
242 Bytes | Ön İzleme İndir |